RSPH vs VHT: Differences, Returns & Fees
Over the year to Nov 18, 2026, RSPH returned +29.7% to VHT's +19.7%; 49% of their weight is in the same names.
- Return gap
- +10.0 pts1 year to Nov 18, 2026: RSPH ahead, total return
- Fee gap
- 0.31 ptsA year: RSPH 0.40%, VHT 0.09%, per filings dated Jun 30, 2026 and Aug 27, 2026
- Overlap
- 49%Share of the two books held in common, holdings dated Nov 17, 2026 and Oct 31, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
RSPH +29.7%, VHT +19.7%: RSPH +10.0 pts ahead, 1 year, Nov 18, 2025 to Nov 18, 2026.
ShareUse this comparison
Client brief:
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
Cost to trade
Hypothetical. A $10,000 order in RSPH costs about $3.50 one way and $7.00 in and out, at a median spread of 0.07%. The 0.07% spread is RSPH’s 30-day median, from Invesco (fund page).
Fees over time
Hypothetical. $10,000 in RSPH for 10 years at 0.40% a year costs about $664 in fees and lost growth; VHT at 0.09% would cost $151. Assumes 6% a year before fees, a sample rate, not a forecast.
Key numbers
VHT costs 0.31 points a year less; their one-year returns differ by 10.0 points.
Pair scorecard
Open the table
| Total return, 1 year | +29.7% | +19.7% |
|---|---|---|
| Below its high | 4.0%, high on Nov 4, 2026 | 4.8%, high on Nov 4, 2026 |
| What it tracks | S&P 500 Equal Weight Health Care Index | MSCI US Investable Market Index (IMI)/Health Care 25/50 |
| Expense ratio | 0.40% | 0.09% |
| Net assets, RSPH as of Nov 17, 2026 and VHT as of Oct 31, 2026 | $1.0bn | $20.8bn |
| Holdings in common | 49% | |
| Top ten holdings, share of the fund | 19.3% | 53.4% |
The numbers behind it
Net assets: $1.0bn on Nov 17, 2026 for Invesco S&P 500 Equal Weight Health Care ETF, and $20.8bn on Oct 31, 2026 for Vanguard Health Care ETF.
Holdings in common uses holdings dated Oct 31, 2026 and Nov 17, 2026.
What they share
By the books each fund has filed, RSPH and VHT hold 49% of their money in the same securities at the same weight. Holdings dated Oct 31, 2026 and Nov 17, 2026.
half
49% in common
Held in common
Show all 12 holdings
| Eli Lilly & Co | 1.88% | 14.69% |
| Intuitive Surgical Inc | 1.83% | 1.98% |
| Gilead Sciences Inc | 1.75% | 2.74% |
| Amgen Inc | 1.75% | 3.25% |
| AbbVie Inc | 1.75% | 6.74% |
| Thermo Fisher Scientific Inc | 1.70% | 3.35% |
| Danaher Corp | 1.66% | 1.92% |
| Medtronic PLC | 1.67% | 1.60% |
| Johnson & Johnson | 1.57% | 8.40% |
| Pfizer Inc | 1.56% | 2.25% |
| Vertex Pharmaceuticals Inc | 1.54% | 1.84% |
| McKesson Corp | 1.84% | 1.51% |
Only in RSPH
Show all 2 holdings
| Invesco Government & Agency Portfolio | 0.03% |
| SECURITIES LENDING - BNYM | 0.00% |
Only in VHT
Show all 8 holdings
| Natera Inc | 0.73% |
| Revolution Medicines Inc | 0.42% |
| Insmed Inc | 0.31% |
| Tenet Healthcare Corp | 0.30% |
| United Therapeutics Corp | 0.30% |
| Alnylam Pharmaceuticals Inc | 0.28% |
| Guardant Health Inc | 0.28% |
| Roivant Sciences Ltd | 0.25% |
Side by side
Open the table
| Fund | Invesco S&P 500 Equal Weight Health Care ETF | Vanguard Health Care ETF |
| Where it sits | Stock ETF | Stock ETF |
| Issuer | Invesco | Vanguard |
| What it is | Tracks an index | Tracks an index of Health Care |
| Total return, 1 year | +29.7% | +19.7% |
| Its benchmark over the same days | not measured | +19.8% (FHLC) |
| Gap to its benchmark | not measured | −0.1 pts vs FHLC |
| Expense ratio | 0.40% | 0.09% |
| Already in the S&P 500 | 100.0% | 86.7% |
| Holdings | 63 | 410 |
| Net assets, RSPH as of Nov 17, 2026 and VHT as of Oct 31, 2026 | $1.0bn | $20.8bn |
RSPH and VHT on the fields both publish, as of Nov 18, 2026. Source: ETFIQ.
From Nov 2006 to Nov 2026, RSPH returned more: +843.9% to +729.8%. VHT swung slightly less: 17.0% to 18.0%. VHT fell slightly less at its worst: −38.1% to −39.5%.
Full scorecard
Open the table
| Total return | +843.9% | +729.8% | RSPH | Price change plus distributions, reinvested. |
| Annualized | +11.8% | +11.1% | RSPH (slight) | Total return as a yearly rate. |
| Price return | +735.3% | +508.9% | RSPH | Price change alone, distributions left out. |
| Volatility | 18.0% | 17.0% | VHT (slight) | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 12.8% | 12.1% | VHT (slight) | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −39.5% | −38.1% | VHT (slight) | Deepest fall from a high to the low after it. |
| Sharpe | 0.62 | 0.61 | RSPH (slight) | Return above Treasury bills per unit of volatility. |
| Sortino | 0.87 | 0.86 | Tie | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.30 | 0.29 | RSPH (slight) | Annualized return divided by the max drawdown. |
More
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,043 weekly returns. Cash rate: the 13-week Treasury bill.
About RSPH
RSPH tracks an index. Over the year to Nov 18, 2026 it returned +29.7% with distributions reinvested.
More
The prospectus expense ratio is 0.40% a year. By its holdings published by its issuer for Nov 17, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 63 positions, with the top ten at 19.3%. It sat 4.0% below its high of Nov 4, 2026 on Nov 18, 2026.
About VHT
VHT tracks an index of Health Care. Over the year to Nov 18, 2026 it returned +19.7% with distributions reinvested, against +19.8% for its benchmark, the MSCI US Investable Market Index (IMI)/Health Care 25/50.
More
The prospectus expense ratio is 0.09% a year. By its holdings published by its issuer as of Oct 31, 2026, 87% of the fund by weight is stocks the S&P 500 also holds, across 410 positions, with the top ten at 53.4%. It sat 4.8% below its high of Nov 4, 2026 on Nov 18, 2026.
Questions people ask
Which returned more over the last year, RSPH or VHT?
In the year to Nov 18, 2026, with distributions reinvested, RSPH returned +29.7% and VHT +19.7%.
Which is cheaper, RSPH or VHT?
VHT is cheaper, by 0.31 percentage points a year. That is about $31 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, RSPH against VHT, data as of Nov 18, 2026. https://etfiq.com/compare/any/rsph-vs-vht
ETFIQ. (Nov 18, 2026). RSPH against VHT. Retrieved from https://etfiq.com/compare/any/rsph-vs-vht
[RSPH against VHT (ETFIQ, Nov 18, 2026)](https://etfiq.com/compare/any/rsph-vs-vht)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.